Joint Support Plus
Joint Support Plus, licence 80030435: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Physicians Research Joint Support Plus
- Licence holder
- Natural Professional Therapeutics Inc.
- NPN or DIN-HM
- 80030435
- Status
- Active licence
- Licence date
- 12 March 2012
- Revision date
- 10 February 2014
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 375.0 mg | Not calculated |
| Harpagophytum procumbens Source : Harpagophytum procumbens, racine Extraction ratio : 20.000:1 Dry plant equivalent : 1,000 mg Potency : 5.0 % Harpagoside | 50.0 mg | Not calculated |
| Collagène de type II hydrolysé Source : Hydrolyzed Collagen Type II | 125.0 mg | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 50.0 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylcellulose, Microcrystalline cellulose, Eau purifiée, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2.0 Capsule ; maximum: 2.0 Capsule | minimum: 2.0 Jour(s) ; maximum: 2.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis, a factor in maintaining cartilage and/or joint health, and helps to protect against the deterioration of cartilage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80030435
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.